维普中文期刊产品整合服务
18篇 您的检索式:作者名="Hoeflich C"
    题名 作者 年代 出处 被引量
1Diffusioin barrier properties of TiW between Si and Cu显示文摘Wang S Q Suthar S Hoeflich C 1993J Appl Phys1993,73,:1
2In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models显示文摘Hoeflich KP O'brien C Boyd Z 0,,14:1
3In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models 显示文摘Hoeflich KP O'Brien C Boyd Z 2009Clin Cancer Res2009,15,14:1
4In vivo antitumor activity ofMEK and phosphatidylinositol 3 - kinase inhibitors in basal - likebreast cancer models 显示文摘Hoeflich KP OBrien C Boyd Z 2009Clin Cancer Res2009,15,14:1
5Role of the insulin like growth factor system in adrenocortical growth control and carcinogenesis显示文摘Fottner C Hoeflich A WolfE 2004Horm Metab Res2004,36,:1
6In vivo antiturnor activi- ty of MEK and phosphatidylinositol 3-kinase inhibitors in bas- al-like breast cancer models显示文摘Hoeflich KP O'Brien C Boyd Z 2009Clin Cancer Res2009,15,14:1
7In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibi- tors in basal-like breast cancer models 显示文摘Hoeflich KP O'Brien C Boyd Z 2009Clin Cancer Res2009,15,14:1
8In vivo antitumor aetiv ity of MEK and phosphatidylinositol 3-kinase inhibitors in basal like breast cancer models显示文摘Hoeflich K P O'Brien C Boyd Z 2009Clin Cancer Res2009,15,14:1
9Stroke-in- duced immunodeficiency promotes spon- taneous bacterial infections and is medi- ated by sympathetic activation reversal by post-stroke T helper cell type l-like im- munostimulation显示文摘Prass K Meisel C Hoeflich C 2003J Exp Med2003,198,5:1
10Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition显示文摘Hoeflich KP Merchant M Orr C 2012Cancer Res2012,72,1:1
11In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models显示文摘Hoeflich KP O′Brien C Boyd Z 2009Clin Cancer Res2009,15,14:1
12On the use and misuse of detected onset temperature of calorimetric experiments for reactive chemicals显示文摘Hoeflich T C M S Labarge 2002Journal of Loss Prevention in the Process Industries2002,15,3:1
13Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apo- ptosis and tumor growth inhibition显示文摘Hoeflich KP Merchant M On' C 2012Cancer Res2012,72,1:1
14Oncogenic BRAF is required for tumor growth and maintenance in melanoma models显示文摘Hoeflich K P Gray D C Eby M T 2006Cancer Res2006,66,2:1
15Role of the insulin like growth factor system in adrenocortical growth control and carcinogenesis 显示文摘Fottner C Hoeflich A WolfE 2004Horrn Metab Res2004,36,:1
16In vivo antitumor activity ofMEK and phosphatidylinositol 3 - kinase inhibitors in basal - likebreast cancer models 显示文摘Hoeflich KP OBrien C Boyd Z 2009Clin Cancer Res2009,15,:1
17In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models显示文摘Hoeflich K P O'Brien C Boyd Z 0,,14:1
18Oneogenic BRAF is required for tumor growth and maintenance in melanoma models显示文摘Hoeflich K P Gray D C Eby M T 2006Cancer Res2006,66,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费